Invention Grant
- Patent Title: Benzothiazoles having histamine H3 receptor activity
- Patent Title (中): 具有组胺H3受体活性的苯并噻唑
-
Application No.: US12294756Application Date: 2007-03-22
-
Publication No.: US08394842B2Publication Date: 2013-03-12
- Inventor: Florencio Zaragoza Dorwald , Rolf Hohlweg , Inge Thoger Christensen , Jane Marie Lundbeck , Knud Erik Andersen
- Applicant: Florencio Zaragoza Dorwald , Rolf Hohlweg , Inge Thoger Christensen , Jane Marie Lundbeck , Knud Erik Andersen
- Applicant Address: US NC High Point
- Assignee: High Point Pharmaceuticals, LLC
- Current Assignee: High Point Pharmaceuticals, LLC
- Current Assignee Address: US NC High Point
- Agent Samuel B. Rollins
- Priority: EP06111820 20060328; EP06112425 20060410; EP06026875 20061224
- International Application: PCT/EP2007/052751 WO 20070322
- International Announcement: WO2007/110364 WO 20071004
- Main IPC: A01N43/78
- IPC: A01N43/78 ; A61K31/425 ; C07D277/82
Abstract:
Certain novel benzothiazoles and benzoxazoles, e.g., 2-(piperazin-1-yl)benzothiazoles and 2-(piperazin-1-yl)benzoxazoles, optionally substituted in the 3 and/or 4 positions of the piperazine rings,! of the general formula (1): having histamine H3 antagonistic activity can be used in pharmaceutical compositions.
Public/Granted literature
- US20100298316A1 Benzothiazoles Having Histamine H3 Receptor Activity Public/Granted day:2010-11-25
Information query
IPC分类:
